Biggest News Aggregation in the World
📰 Squarepoint Ops News

Page 102 - Squarepoint Ops News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Squarepoint Ops. Real-time updates on events, politics, business and more.

CK Hutchison Holdings Limited (OTCMKTS:CKHUY) Short Interest Down 62.9% in May

MiMedx Group (NASDAQ:MDXG – Get Rating) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a report issued on Thursday. Separately, HC Wainwright upped their target price on shares of MiMedx Group from $8.00 to $9.50 in a report on Wednesday, May 3rd. MiMedx Group Trading Down 4.7 % Shares of […]
Peterm Carlson Zurcher Kantonalbank Zurich Cantonalbank Robert Benjamin Stein Nisa Investment Advisors Mimedx Group Trading Down Mimedx Group

UGI Co. (NYSE:UGI) Receives $39.50 Consensus Target Price from Brokerages

Shares of UGI Co. (NYSE:UGI – Get Rating) have been given an average rating of “Hold” by the six research firms that are presently covering the firm, MarketBeat.com reports. One analyst has rated the stock with a sell rating and three have issued a hold rating on the company. The average twelve-month target price among […]
Roger Perreault Jpmorgan Chase Co First Trust Advisors Sherbrooke Park Advisers Company Profile Squarepoint Ops
Source: wkrb13.com

Aroundtown (OTCMKTS:AANNF) Trading Down 8.2%

Lifesci Capital downgraded shares of Rain Oncology (NASDAQ:RAIN – Get Rating) from an outperform rating to a market perform rating in a research report report published on Monday, PriceTargets.com reports. Several other research firms have also commented on RAIN. Piper Sandler lowered shares of Rain Oncology from an overweight rating to a neutral rating in […]
United States Piper Sandler Geode Capital Management Alyeska Investment Group Squarepoint Ops Rain Therapeutics Inc

CyberArk Software (NASDAQ:CYBR) Updates FY23 Earnings Guidance

CyberArk Software (NASDAQ:CYBR – Get Rating) issued an update on its FY23 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $0.16-0.38 for the period, compared to the consensus earnings per share estimate of $0.29. The company issued revenue guidance of $724-736 million, compared to the consensus revenue estimate of $730.11 […]
United States Udi Mokady Petah Tikva Alon Cohen Cyberark Software Stock Performance Canaccord Genuity Group

Analysts Set Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Target Price at $50.17

Shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) have received a consensus recommendation of “Moderate Buy” from the six analysts that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average 1 year price target […]
Patrickd Yeramian Hedge Funds Weigh In On Amylyx Pharmaceuticals Goldman Sachs Group Geode Capital Management Putnam Investments Amylyx Pharmaceuticals
Source: wkrb13.com

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Anywhere Real Estate (NYSE:HOUS) Stock Price Down 6.8%

Anywhere Real Estate Inc. (NYSE:HOUS – Get Rating)’s share price dropped 6.8% during mid-day trading on Wednesday . The stock traded as low as $6.00 and last traded at $6.05. Approximately 525,208 shares changed hands during trading, a decline of 71% from the average daily volume of 1,800,872 shares. The stock had previously closed at […]
Jpmorgan Chase Co Realogy Brokerage Group Squarepoint Ops Putnam Investments Apollo Management Holdings Real Estate Company Profile
Source: wkrb13.com

Ovid Therapeutics (NASDAQ:OVID) Trading 0.9% Higher

Ovid Therapeutics Inc. (NASDAQ:OVID – Get Rating) traded up 0.9% during mid-day trading on Wednesday . The company traded as high as $3.55 and last traded at $3.48. 53,116 shares changed hands during trading, a decline of 39% from the average session volume of 87,693 shares. The stock had previously closed at $3.45. Wall Street […]
New York United States Ovid Therapeutics Company Profile America Corp Squarepoint Ops Ovid Therapeutics Inc
Source: wkrb13.com

Gaotu Techedu (NYSE:GOTU) Shares Gap Up to $2.32

Gaotu Techedu Inc. (NYSE:GOTU – Get Rating)’s share price gapped up before the market opened on Friday . The stock had previously closed at $2.32, but opened at $2.45. Gaotu Techedu shares last traded at $2.48, with a volume of 248,057 shares. Analyst Ratings Changes Separately, CLSA upgraded shares of Gaotu Techedu from an “underperform” […]
Gaotu Techedu Xiang Dong Chen Gaotu Techedu Inc Schonfeld Strategic Advisors Mercer Global Advisors Inc Squarepoint Ops
Source: wkrb13.com

View, Inc. (NASDAQ:VIEW) CEO Purchases $17,284.96 in Stock

View, Inc. (NASDAQ:VIEW – Get Rating) CEO Rao Mulpuri bought 75,152 shares of the firm’s stock in a transaction dated Wednesday, May 24th. The shares were acquired at an average price of $0.23 per share, for a total transaction of $17,284.96. Following the acquisition, the chief executive officer now directly owns 589,721 shares of the […]
Rao Mulpuri View Inc Securities Exchange Commission Millennium Management Pricet Rowe Associates Inc Envestnet Asset Management Inc

Fabrinet (NYSE:FN) Director Homa Bahrami Sells 1,400 Shares

Fabrinet (NYSE:FN – Get Rating) Director Homa Bahrami sold 1,400 shares of the business’s stock in a transaction on Wednesday, May 24th. The stock was sold at an average price of $98.05, for a total transaction of $137,270.00. Following the completion of the sale, the director now owns 32,739 shares in the company, valued at […]
Homa Bahrami Securities Exchange Commission Needham Company Royal Bank Geode Capital Management Squarepoint Ops
Source: wkrb13.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science